title: Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry.
abstract: Left atrial appendage closure is a non-pharmacological alternative for stroke prevention in high-risk patients with non-valvular atrial fibrillation. The objective of the multicentre EWOLUTION registry was to obtain clinical data on procedural success and complications, and long-term patient outcomes, including bleeding and incidence of stroke/transient ischaemic attack (TIA). Here, we report on the peri-procedural outcomes of up to 30 days.
  
  
  
  Baseline/implant data are available for 1021 subjects. Subjects in the study were at high risk of stroke (average CHADS2 score: 2.8 ± 1.3, CHA2DS2-VASc: 4.5 ± 1.6) and moderate-to-high risk of bleeding (average HAS-BLED score: 2.3 ± 1.2). Almost half of the subjects (45.4%) had a history of TIA, ischaemic stroke, or haemorrhagic stroke; 62% of patients were deemed unsuitable for novel oral anticoagulant by their physician. The device was successfully deployed in 98.5% of patients with no flow or minimal residual flow achieved in 99.3% of implanted patients. Twenty-eight subjects experienced 31 serious adverse events (SAEs) within 1 day of the procedure. The overall 30-day mortality rate was 0.7%. The most common SAE occurring within 30 days of the procedure was major bleeding requiring transfusion. Incidence of SAEs within 30 days was significantly lower for subjects deemed to be ineligible for oral anticoagulation therapy (OAT) compared with those eligible for OAT (6.5 vs. 10.2%, P = 0.042).
  
  
  
  Left atrial appendage closure with the WATCHMAN device has a high success rate in complete LAAC with low peri-procedural risk, even in a population with a higher risk of stroke and bleeding, and multiple co-morbidities. Improvement in implantation techniques has led to a reduction of peri-procedural complications previously limiting the net clinical benefit of the procedure.
authors.affiliation: Cardiology Department, St Antonius Hospital, PO 2500, 3430 EM Nieuwegein, the Netherlands l.boersma@antoniusziekenhuis.nl l.boersma@antonius.net.
authors.forename: Lucas V A
authors.initials: LV
authors.lastname: Boersma
authors.affiliation: Cardioangiologisches Centrum Bethanien, Frankfurt, Germany.
authors.forename: Boris
authors.initials: B
authors.lastname: Schmidt
authors.affiliation: John Radcliffe Hospital, Oxford, UK.
authors.forename: Timothy R
authors.initials: TR
authors.lastname: Betts
authors.affiliation: Cardio Vasculäres Centrum Sankt Katharinen, Frankfurt, Germany.
authors.forename: Horst
authors.initials: H
authors.lastname: Sievert
authors.affiliation: Ospedale Ferrarotto Alessi, Catania, Italy.
authors.forename: Corrado
authors.initials: C
authors.lastname: Tamburino
authors.affiliation: CHU Henri Mondor, Créteil, France.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Teiger
authors.affiliation: State Research Institute of Circulation Pathology, Novosibirsk, Russia.
authors.forename: Evgeny
authors.initials: E
authors.lastname: Pokushalov
authors.affiliation: Vivantes Klinikum im Friedrichshain, Berlin, Germany.
authors.forename: Stephan
authors.initials: S
authors.lastname: Kische
authors.affiliation: Elisabeth Krankenhaus Essen, Essen, Germany.
authors.forename: Thomas
authors.initials: T
authors.lastname: Schmitz
authors.affiliation: Boston Scientific Corp., Minneapolis, MN, USA.
authors.forename: Kenneth M
authors.initials: KM
authors.lastname: Stein
authors.affiliation: Herzkatheter Asklepios Wandsbek, Hamburg, Germany.
authors.forename: Martin W
authors.initials: MW
authors.lastname: Bergmann
mesh_terms: D000925:Anticoagulants; D020517:Atrial Appendage; D001281:Atrial Fibrillation; D006801:Humans; D012042:Registries; D020521:Stroke; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants
keywords: Atrial fibrillation; Left atrial appendage; Stroke
references.citation: J Am Coll Cardiol. 2014 Jul 8;64(1):1-12
references.pmid: 24998121
references.citation: Circulation. 2011 Feb 1;123(4):417-24
references.pmid: 21242484
references.citation: Circulation. 2011 Jun 14;123(23):2736-47
references.pmid: 21670242
references.citation: Eur Heart J. 2011 Jan;32(2):205-17
references.pmid: 21216739
references.citation: Lancet. 2009 Aug 15;374(9689):534-42
references.pmid: 19683639
references.citation: J Am Coll Cardiol. 2013 Jun 25;61(25):2551-6
references.pmid: 23583249
references.citation: Stroke. 2014 Dec;45(12):3754-832
references.pmid: 25355838
references.citation: Eur Heart J. 2012 Nov;33(21):2719-47
references.pmid: 22922413
references.citation: EuroIntervention. 2016 Feb;11(10 ):1170-9
references.pmid: 25604089
references.citation: JAMA. 2014 Nov 19;312(19):1988-98
references.pmid: 25399274
references.citation: Ann Thorac Surg. 1996 Feb;61(2):755-9
references.pmid: 8572814
references.citation: Eur Heart J. 2014 Oct 1;35(37):2541-619
references.pmid: 25173339
references.citation: Catheter Cardiovasc Interv. 2016 Sep;88(3):460-5
references.pmid: 26719158
references.citation: EuroIntervention. 2015 Jan;10(9):1109-25
references.pmid: 25169595